Grace Therapeutics, Inc. (GRCE) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 |
|---|
| Total Current Assets | 17.38M | 19.21M | 17.3M | 20.52M | 22.71M | 11.94M | 16.06M | 20.43M | 24.01M | 26.88M | 28.89M | 23.61M | 29.29M | 33.43M | 37.51M | 41.25M | 45.53M | 49M | 54.55M | 74.68M |
| Cash & Short-Term Investments | 16.98M | 18.67M | 16.86M | 20M | 22.13M | 11.05M | 15.17M | 19.41M | 23M | 25.11M | 27.01M | 21.65M | 27.89M | 31.26M | 34.94M | 38.39M | 43.66M | 46.33M | 50.79M | 71.39M |
| Cash Only | 16.98M | 18.67M | 16.86M | 20M | 22.13M | 11.05M | 15.15M | 19.39M | 23M | 18.55M | 26.99M | 21.63M | 27.88M | 26.24M | 34.93M | 38.38M | 30.34M | 33.01M | 36.93M | 50.68M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 15K | 15K | 0 | 6.57M | 15K | 15K | 15K | 5.01M | 14K | 16K | 13.32M | 13.31M | 13.86M | 20.71M |
| Accounts Receivable | 20K | 20K | 20K | 20K | 126K | 301K | 415K | 398K | 722K | 959K | 837K | 837K | 802K | 778K | 859K | 964K | 548K | 238K | 813K | 554.06K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 352K | 352K | 352K | 602K | 587K | 764K | 962.18K |
| Total Non-Current Assets | 49.27M | 49.28M | 49.28M | 49.28M | 49.28M | 49.28M | 49.29M | 49.29M | 49.29M | 49.3M | 49.32M | 49.42M | 49.83M | 83.37M | 83.41M | 83.68M | 83.09M | 65.23M | 65.25M | 81.62K |
| Property, Plant & Equipment | 8K | 11K | 12K | 14K | 15K | 19K | 21K | 23K | 24K | 35K | 57K | 155K | 567K | 599K | 632K | 909K | 315K | 22K | 43K | 81.62K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 8.14M | 8.14M | 8.14M | 8.14M | 8.14M | 8.14M | 8.14M | 8.14M | 8.14M | 8.14M | 8.14M | 8.14M | 8.14M | 12.96M | 12.96M | 12.96M | 12.96M | 0 | 0 | 0 |
| Intangible Assets | 41.13M | 41.13M | 41.13M | 41.13M | 41.13M | 41.13M | 41.13M | 41.13M | 41.13M | 41.13M | 41.13M | 41.13M | 41.13M | 69.81M | 69.81M | 69.81M | 69.81M | 65.21M | 65.21M | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 66.65M | 68.49M | 66.58M | 69.81M | 71.99M | 61.22M | 65.35M | 69.72M | 73.3M | 76.19M | 78.21M | 73.03M | 79.12M | 116.8M | 120.91M | 124.93M | 128.62M | 114.23M | 119.8M | 74.76M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -7.42% | 11.86% | 1.88% | 0.12% | -1.78% | -19.64% | -16.44% | -4.54% | -7.36% | -34.77% | -35.32% | -41.54% | -38.48% | 2.25% | 0.93% | 67.1% | 63.93% | 195.21% | 550.89% | 173.69% |
| Total Current Liabilities | 2.15M | 1.28M | 1.25M | 2.31M | 1.93M | 1.97M | 2.67M | 2.6M | 1.68M | 1.77M | 1.4M | 1.97M | 3.41M | 3.43M | 3.81M | 3.71M | 3.26M | 2.9M | 4.48M | 2.9M |
| Accounts Payable | 702K | 156.42K | 459K | 1.34M | 601K | 665K | 1.68M | 1.55M | 1.01M | 913K | 685K | 607K | 1.24M | 3.36M | 3.73M | 3.06M | 3.16M | 2.84M | 4.43M | 2.82M |
| Days Payables Outstanding | 19.31K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24K | 46K | 80K | 75K | 0 | 0 | 0 | 104K | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.44M | 507.58K | 0 | 0 | 0 | 814K | 0 | 0 | 0 | 532K | 460K | 994K | 946K | 0 | 0 | 0 | 0 | 32K | 0 | 0 |
| Current Ratio | 8.10x | 14.96x | 13.89x | 8.87x | 11.77x | 6.06x | 6.01x | 7.86x | 14.26x | 15.19x | 20.68x | 12.01x | 8.59x | 9.74x | 9.86x | 11.13x | 13.97x | 16.91x | 12.19x | 25.75x |
| Quick Ratio | 8.10x | 14.96x | 13.89x | 8.87x | 11.77x | 6.06x | 6.01x | 7.86x | 14.26x | 15.19x | 20.68x | 12.01x | 8.59x | 9.74x | 9.86x | 11.13x | 13.97x | 16.91x | 12.19x | 25.75x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 612K | 2.31M | 2.51M | 3.94M | 3.45M | 7.11M | 6.54M | 7.75M | 9.87M | 9.73M | 10.07M | 7.06M | 7.76M | 16.65M | 16.94M | 16.82M | 17.09M | 268K | 1.12M | 5.75M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 410K | 430K | 450K | 174K | 191K | 0 | 0 | 0 |
| Deferred Tax Liabilities | 612K | 2.31M | 2.31M | 2.31M | 2.31M | 3.33M | 3.94M | 4.79M | 5.51M | 6.4M | 6.61M | 7.06M | 7.35M | 16.22M | 16.49M | 16.65M | 16.89M | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 201K | 1.63M | 1.14M | 3.78M | 2.6M | 2.96M | 4.36M | 3.33M | 3.46M | -1 | 0 | 0 | 0 | 0 | 10K | 268K | 1.12M | 5.75M |
| Total Liabilities | 2.76M | 3.6M | 3.76M | 6.25M | 5.38M | 9.09M | 9.21M | 10.35M | 11.56M | 11.51M | 11.46M | 9.02M | 11.17M | 20.08M | 20.75M | 20.53M | 20.35M | 3.17M | 5.59M | 8.65M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24K | 46K | 80K | 485K | 503K | 520K | 819K | 295K | 22K | 43K | 81.62K |
| Net Debt | -16.98M | -18.67M | -16.86M | -20M | -22.13M | -11.05M | -15.15M | -19.39M | -23M | -18.52M | -26.95M | -21.55M | -27.39M | -25.74M | -34.41M | -37.56M | -30.04M | -32.99M | -36.89M | -50.59M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | -75.11x | - | - | - | -37.42x | - | - | - |
| Total Equity | 63.9M | 64.89M | 62.82M | 63.55M | 66.61M | 52.14M | 56.13M | 59.36M | 61.74M | 64.68M | 66.75M | 64.01M | 67.95M | 96.72M | 100.16M | 104.4M | 108.27M | 111.06M | 114.2M | 66.11M |
| Equity Growth % | -4.07% | 24.46% | 11.91% | 7.05% | 7.88% | -19.39% | -15.9% | -7.26% | -9.14% | -33.13% | -33.36% | -38.69% | -37.24% | -12.91% | -12.29% | 57.92% | 54.84% | 238.24% | 867.3% | 341.7% |
| Book Value per Share | 3.87 | 3.83 | 3.94 | 3.99 | 4.76 | 4.53 | 4.88 | 5.43 | 6.04 | 5.62 | 8.84 | 8.61 | 9.14 | 13.01 | 13.49 | 14.13 | 16.01 | 15.05 | 20.90 | 15.23 |
| Total Shareholders' Equity | 63.9M | 64.89M | 62.82M | 63.55M | 66.61M | 52.14M | 56.13M | 59.36M | 61.74M | 64.68M | 66.75M | 64.01M | 67.95M | 96.72M | 100.16M | 104.4M | 108.27M | 111.06M | 114.2M | 66.11M |
| Common Stock | 1K | 1K | 1K | 1K | 1K | 1K | 261.04M | 261.04M | 261.04M | 261.04M | 261.04M | 258.29M | 258.29M | 258.29M | 258.29M | 258.19M | 257.99M | 257.99M | 258M | 243.88M |
| Retained Earnings | -228.48M | -227.3M | -224.99M | -224.05M | -220.69M | -221.32M | -217.17M | -213.74M | -211.12M | -207.95M | -205.56M | -202.29M | -198.27M | -169.18M | -165.29M | -160.36M | -155.84M | -151.93M | -148.16M | -184.44M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M | -6.53M | -6.72M | -6.89M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |